Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MATCHES-Novel: MAking Telehealth Delivery of Cancer Care at Home Effective and Safe for Novel Therapies: A Hospital-at-Home Model for Tarlatamab Delivery

NCT06957314 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT06957314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06957314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MATCHES-Novel: MAking Telehealth Delivery of Cancer Care at Home Effective and Safe for Novel Therapies: A Hospital-at-Home Model for Tarlatamab Delivery
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
April 23, 2025
Completion date
April 23, 2028
Enrollment
70 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung carcinoma, small-cell lung cancer